Skip to content
Top Globe News – Lifestyle
Author:
Sanofi Winthrop Industrie
Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease
March 31, 2026
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
March 18, 2026
←
Previous Page
1
2
3
4